- Home
- CLSD vs NTRB Comparison
CLSD vs NTRB Comparison
Compare CLSD & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- NTRB
- Stock Information
- Founded
- CLSD 2011
- NTRB 2016
- Country
- CLSD United States
- NTRB United States
- Employees
- CLSD N/A
- NTRB N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- CLSD Health Care
- NTRB Health Care
- Exchange
- CLSD Nasdaq
- NTRB Nasdaq
- Market Cap
- CLSD 81.2M
- NTRB 84.1M
- IPO Year
- CLSD 2016
- NTRB N/A
- Fundamental
- Price
- CLSD $0.95
- NTRB $7.46
- Analyst Decision
- CLSD Strong Buy
- NTRB Buy
- Analyst Count
- CLSD 6
- NTRB 1
- Target Price
- CLSD $5.33
- NTRB $13.00
- AVG Volume (30 Days)
- CLSD 214.9K
- NTRB 216.4K
- Earning Date
- CLSD 03-11-2025
- NTRB 12-04-2024
- Dividend Yield
- CLSD N/A
- NTRB N/A
- EPS Growth
- CLSD N/A
- NTRB N/A
- EPS
- CLSD N/A
- NTRB N/A
- Revenue
- CLSD $7,703,000.00
- NTRB $2,021,771.00
- Revenue This Year
- CLSD N/A
- NTRB $7.95
- Revenue Next Year
- CLSD $91.87
- NTRB $538.25
- P/E Ratio
- CLSD N/A
- NTRB N/A
- Revenue Growth
- CLSD 248.39
- NTRB N/A
- 52 Week Low
- CLSD $0.80
- NTRB $2.22
- 52 Week High
- CLSD $2.12
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- CLSD 43.06
- NTRB 55.21
- Support Level
- CLSD $1.00
- NTRB $6.68
- Resistance Level
- CLSD $1.09
- NTRB $8.24
- Average True Range (ATR)
- CLSD 0.07
- NTRB 0.74
- MACD
- CLSD -0.01
- NTRB -0.11
- Stochastic Oscillator
- CLSD 16.30
- NTRB 43.32
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.